Edition:
United Kingdom

STRATA Skin Sciences Inc (SSKN.OQ)

SSKN.OQ on NASDAQ Stock Exchange Capital Market

1.20USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,161
52-wk High
$4.88
52-wk Low
$1.06

Chart for

About

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and... (more)

Overall

Beta: 0.50
Market Cap(Mil.): $4.36
Shares Outstanding(Mil.): 2.48
Dividend: --
Yield (%): --

Financials

  SSKN.OQ Industry Sector
P/E (TTM): -- 148.40 32.74
EPS (TTM): -2.66 -- --
ROI: -15.67 9.37 14.38
ROE: -40.41 14.69 16.07

BRIEF-Strata Skin Sciences Inc - ‍On March 30, 2018, Co Entered Into Securities Purchase Agreements And Subscription Agreements -- SEC Filing​

* CO WILL ISSUE 15.7 MILLION SHARES OF CO'S COMMON STOCK TO A GROUP OF INVESTORS LED BY ACCELMED GROWTH PARTNERS L.P. FOR $17.0 MILLION

02 Apr 2018

BRIEF-STRATA Skin Sciences Appoints Dolev Rafaeli As Interim CEO

* STRATA SKIN SCIENCES ANNOUNCES $17 MILLION EQUITY FINANCING LED BY ACCELMED GROWTH PARTNERS; APPOINTMENT OF INDUSTRY VETERAN AS INTERIM CEO

02 Apr 2018

BRIEF-Strata Skin Sciences Delays Q4 Results Partly Due To Extended Power Outage At Horsham

* STRATA SKIN SCIENCES, INC. DELAYS FOURTH QUARTER AND FISCAL 2017 FINANCIAL RESULTS

06 Mar 2018

BRIEF-Strata Skin Sciences reports Q3 loss of $5.52 per share

* Strata skin sciences reports third quarter 2017 financial results

09 Nov 2017

BRIEF-Leviticus Partners reports 9.69 pct passive stake in Strata Skin Sciences

* Says reports 9.69 pct passive stake in Strata Skin Sciences Inc as of Oct 24, 2017 - SEC filing‍​ Source text - (http://bit.ly/2h6vUO5)

02 Nov 2017

Earnings vs. Estimates